Hostname: page-component-cc8bf7c57-77pjf Total loading time: 0 Render date: 2024-12-12T00:35:46.715Z Has data issue: false hasContentIssue false

Role of Blonanserin in Cannabis-induced Psychosis

Published online by Cambridge University Press:  15 April 2020

D. Pan
Affiliation:
Psychiatry, Saltlake Mindset, Kolkata, India
A. Mallick
Affiliation:
Psychiatry, Saltlake Mindset, Kolkata, India

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Cannabis-induced psychosis is not uncommon and a lot of antipsychotics have been in use in clinical practice to address the problem. However, Blonanserin, a relatively new atypical antipsychotic has not yet been tested in cases like this.

Objective and Aims

This study aims to understand any possible role of Blonanserin in patients of cannabis -induced psychosis.

Methods

We recruited 20 patients as per DSM V criteria, coded 292.5,of cannabis-induced psychosis into the study and randomly divided them into 10 each of 2 groups, Group A and Group B and administered Blonanserin (4-24mg)and Placebo respectively for the two groups and then followed up for 6 months. All patients were assessed for their psychotic symptoms before and after the study, using Brief Psychiatric Rating Scale (BPRS) and statistically analysed.

Result

Gr A patients, overall, showed better response (at least 50%reduction in BPRS score from the baseline in all patients)in comparison to the Gr B patients in terms of their psychotic symptoms as we could analyse from the t score measurement difference between the two groups before and after the study. Significantly, Blonanserin was very well tolerated.

Discussion

While several antipsychotic drugs have already been proven beneficial in the treatment of cannabis-induced psychosis, almost all of them have troublesome side effects and even some of them, like Risperidone has actually been found to increase craving for cannabis in some patients, as available literature suggests. However, Blonanserin, because of its overall favourable pharmacological profile might be a very useful drug in such cases.

Type
Article: 0825
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.